Multiple biochemical tumor markers in seminoma. A double-blind study

Area of Science:

• Oncology
• Biochemistry
• Clinical Diagnostics

Background:

• Established biochemical tumor markers are crucial for nonseminomatous testicular cancer.
• Seminoma patients often lack frequent and reliable serum tumor markers.
• This study addresses the need for better diagnostic tools in seminoma management.

Purpose of the Study:

• To evaluate the utility of specific biochemical markers in seminoma patients.
• To determine the frequency of elevated markers in active seminoma.
• To assess the potential of these markers for clinical monitoring.

Main Methods:

• A double-blind study involving 89 patients with seminoma.
• Analysis of serum levels of placental alkaline phosphatase (PLAP), gamma-glutamyl transpeptidase (GGT), human chorionic gonadotropin (hCG), and alpha-fetoprotein (AFP).
• Correlation of marker levels with the presence of active tumor.

Main Results:

• Elevated serum PLAP was found in 40% (12/30) of patients with active tumor.
• Elevated serum GGT was observed in 33% (10/30) of patients with active tumor.
• Eighty percent of patients with active seminoma showed detectable levels of at least one marker.

Conclusions:

• Serial monitoring of PLAP and GGT can aid in the detection and management of seminoma.
• These biochemical markers offer improved efficacy for monitoring seminoma patients.
• Consideration of false-positive/negative rates and marker half-lives is essential for accurate interpretation.